# 68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients

> **NCT01527058** · EARLY_PHASE1 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** 68Ga-BNOTA-PRGD2

## Key facts

- **NCT ID:** NCT01527058
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-12
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01527058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01527058, "68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients". Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/clinical/NCT01527058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*